VCM
ALT icon

Voleon Capital Management’s Altimmune ALT Stock Holding History

Voleon Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.6K Sell
27,142
-19,913
-42% -$84.5K ﹤0.01% 768
2025
Q4 		$170K Buy
+47,055
New +$205K ﹤0.01% 732

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Voleon Capital Management's ALT Position: Q1 2026 in Review

Voleon Capital Management reduced its Altimmune (ALT) stake by 42% in Q1 2026, selling an estimated $84.5K and leaving 27,142 shares worth $83.6K. The position accounts for ﹤0.01% of the portfolio, ranked #768.

Voleon Capital Management first reported a position in ALT in Q4 2025 and has held it in 2 quarters since. The position peaked at $170K in Q4 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Voleon Capital Management held 27,142 shares of Altimmune worth $83.6K as of Q1 2026.
  • Voleon Capital Management sold 19,913 Altimmune shares in Q1 2026, an estimated $84.5K.
  • Altimmune made up ﹤0.01% of Voleon Capital Management's portfolio in Q1 2026, its #768 holding.
  • Voleon Capital Management first reported a position in Altimmune in Q4 2025 and has held it in 2 quarters since.
  • Voleon Capital Management's Altimmune position peaked at $170K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.